Clinical Trial: Evaluation of the Performance and Safety of a Single-dose Hyaluronic Acid (Promovia Hydro Balance) in the Treatment of Non-traumatic Degenerative Meniscus Tears

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07539194) titled 'Evaluation of the Performance and Safety of a Single-dose Hyaluronic Acid (Promovia Hydro Balance) in the Treatment of Non-traumatic Degenerative Meniscus Tears' on April 13.

Brief Summary: Evaluation of the performance and safety of a single-dose hyaluronic acid (Promovia hydro balance) in the treatment of non-traumatic degenerative meniscus tears

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Meniscus Tears

Intervention: DEVICE: Promovia Hydro Balance 100 mg, Hyaluronic acid sodium salt and trehalose

Promovia Hydro Balance 100 mg

Recruitment Status: RECRUITING

Sponsor: Innate srl

Published by HT Digita...